The Role Of Botox Injections In Toe Walking Treatment
Published on: June 5, 2025
The Role Of Botox Injections In Toe Walking Treatment
Article author photo

Vasudha Handa

Master's degree, Microbiology, General, Panjab University

Article reviewer photo

Mahhum Saqib

BSc Pharmacology Undergraduate, King’s College London

What is toe walking?

Toe walking is a gait pattern where a child walks on their toes or the ball of their foot without the heel touching the ground. It is characterised by the absence of a heel strike during the initial contact phase of the gait cycle. In children aged two or under, toe walking is generally considered a normal gait variation. However, most children outgrow toe walking and begin to walk with a normal heel-to-toe pattern after the age of  If toe walking continues after this age, it is recommended to consult a health professional.1 Toe walking can be associated with underlying health conditions such as cerebral palsy, muscular dystrophy, autism spectrum disorders, or other lower limb injuries. When no specific medical reason can be identified, it is referred to as idiopathic toe walking (ITW). Common treatments for persistent toe walking include physical therapy, bracing, casting, and in some cases, surgery.

Botulinum toxin a (BTX-A) injections

 Botulinum toxin A (BTX-A), commonly known as Botox, is frequently used in children with tight muscles to address conditions like spastic equinus, where the foot is excessively plantarflexed. BTX-A achieves muscle weakening by blocking the release of acetylcholine at the neuromuscular junction. Acetylcholine is a neurotransmitter that normally binds to receptors on muscle fibres, triggering muscle contraction. By preventing the release of acetylcholine, BTX-A effectively causes temporary muscle paralysis.

The procedure involves injecting BTX-A into specific calf muscles, typically the gastrocnemius and soleus. Though not explicitly mentioned in the provided search results, general anaesthesia is often used. The number of injections can vary, but four injections are typically administered in each leg. The duration of the injection procedure is around 15 minutes.2

The effects of BTX-A injections are not permanent, generally lasting for approximately four months. During this period, the reduction in muscle spasticity can lead to improved joint function and range of motion. A study noted improvements in ankle and knee movements just five days post-injection. The injections can be repeated approximately every six months as needed to maintain the therapeutic effect. It's worth noting that while BTX-A can improve ankle dorsiflexion, it may not always resolve related conditions like knee hyperextension, suggesting the need to consider other contributing factors.3

Effectiveness of BTX-A injections

The use of Botulinum Toxin A (BTX-A) has shown promising results in improving walking patterns in children with idiopathic toe-walking (ITW). A single injection of BTX-A, when combined with an exercise program, can significantly enhance gait characteristics.4 Studies indicate that this combination leads to improved foot contact patterns, with a notable decrease in toe walking observed shortly after treatment and maintained over time.

Furthermore, research suggests that combining repeated BTX-A injections with conservative treatments, such as physiotherapy and bracing, yields better outcomes than conservative treatment alone. While both approaches show improvement, the group receiving BTX-A injections demonstrated more significant changes in their walking patterns.5 Gait analysis reveals substantial improvements, characterised by a decrease in the plantarflexion angle and an increase in the dorsiflexion angle during walking.

Follow-up studies report that between 27% to 100% of participants ceased toe-walking within a follow-up period ranging from 2 to 30 months post-treatment. This variation reflects individual differences in response to the treatment and underscores the need for tailored therapeutic approaches. Overall, while BTX-A injections can facilitate improvements in gait, the ultimate goal of completely stopping toe-walking is not consistently achieved, indicating that additional interventions may be necessary for some children.6

BTX-A injections combined with other treatments

BTX-A injections are often combined with other treatments like serial casting and bracing to address toe walking in children. These injections weaken calf muscles, potentially making subsequent interventions more effective. However, studies vary on whether combining BTX-A injections with casting yields significantly better results than casting alone. 

Here are some combined treatments:

Serial casting post-injection

Serial casting(a treatment that uses a series of casts to stretch muscles and joints in the arms and legs)typically begins one week after the Botox injection. However, one study implemented serial casting three weeks after the BTX-A injection. This involves applying a series of casts to progressively increase the ankle's range of motion.

Impact of botox on casting

Weakening the calf muscles with Botox can facilitate the casting process, potentially making it easier and more effective. BTX-A paralyses muscles by blocking the neurotransmission pathway, which can allow for greater gains in range of motion during casting.7

Duration of casting

Casts are generally applied for a period of 4 to 6 weeks. During this time, the joint is held in a stretched position to encourage lengthening of the muscles and tendons.

Comparison of casting-only vs. combined approach

Interestingly, one study found no significant differences between casting-only and casting with BTX-A injections when treating children with idiopathic toe-walking. This suggests that casting alone can be an effective treatment option for some children.

Post-casting management

Following cast removal, young patients may be fitted with arch supports, and a night-stretching Ankle-Foot Orthosis (AFO) is often used for six months to maintain the gains achieved during casting. AFO splints sometimes follow serial casting

Summary

 While Botulinum Toxin A (BTX-A) injections can be a valuable tool in addressing toe walking, it's important to note that the ultimate goal of completely ceasing toe-walking is only occasionally reached. Many individuals may experience improvement but not a complete resolution of the condition. Another consideration is that most insurance plans do not cover Botox injections for toe walking, potentially making this treatment option inaccessible for some families. Further research is needed to optimise the effectiveness of BTX-A treatment for idiopathic toe-walking. Areas for exploration include whether repeated injections, the addition of bracing, or more vigorous physiotherapy programs can enhance outcomes.

FAQ’s

Here are 10 frequently asked questions (FAQs) about Botox injections for toe walking, based on the provided search results:

Q1: What is toe walking, and when is it a concern?

Toe walking is walking on the toes or balls of the feet without the heel touching the ground. It's normal in young children (under two years old), but concerning if it persists beyond that age.

Q2: How can botox injections help treat toe walking?

Botox (Botulinum Toxin A) weakens tight calf muscles by blocking nerve signals, which reduces muscle contraction and improves ankle range of motion.

Q3: How is the botox injection procedure performed?

The procedure involves injecting Botox into the gastrocnemius and soleus muscles of the calf. The number of injections can vary, but four injections are typically administered in each leg.

Q4: How long do the effects of botox injections last?

The effects of Botox typically last around four months, and injections can be repeated every six months if needed.

Q5: Are botox injections used alone, or are they combined with other treatments?

Botox injections are often combined with other treatments like physical therapy, serial casting, and bracing to improve outcomes.

Q6: What is serial casting, and how does it relate to botox injections?

Serial casting involves applying a series of casts to gradually increase the ankle's range of motion. It often begins about one week after Botox injections, when the calf muscles are weakened.

Q7: Will botox injections completely stop toe walking?

 While Botox injections can improve gait patterns, completely stopping toe walking is only sometimes achieved. Further interventions may be necessary.

Q8: Are botox injections for toe walking covered by insurance?

Most insurance plans do not cover Botox injections for toe walking, potentially making the treatment inaccessible for some.

References

  1. Toe walking - orthoinfo - american academy of orthopaedic surgery [Internet]. [cited 2025 Feb 14]. Available from: https://www.orthoinfo.org/en/diseases--conditions/toe-walking.
  2. Toe walking [Internet]. 2024 [cited 2025 Feb 14]. Available from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/toe-walking
  3. Toe walking in children - signature medical group [Internet]. [cited 2025 Feb 14]. Available from: https://www.signaturemedicalgroup.com/news/specialties/orthopedics/toe-walking-in-children/
  4. Brunt, D., Woo, R., Kim, H. D., Ko, M. S., Senesac, C., & Li, S. (2004). Effect of botulinum toxin type A on gait of children who are idiopathic toe-walkers. Journal of Surgical Orthopaedic Advances, 13(3), 149-155.
  5. Sätilä H, Beilmann A, Olsén P, Helander H, Eskelinen M, Huhtala H. Does botulinum toxin a treatment enhance the walking pattern in idiopathic toe-walking? Neuropediatrics [Internet]. 2016 Apr 18 [cited 2025 Feb 14];47(03):162–8. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0036-1582138
  6. Engström P, Gutierrez-Farewik EM, Bartonek Å, Tedroff K, Orefelt C, Haglund-Åkerlind Y. Does botulinum toxin A improve the walking pattern in children with idiopathic toe-walking? Journal of Children’s Orthopaedics [Internet]. 2010 Aug [cited 2025 Feb 14];4(4):301–8. Available from: https://journals.sagepub.com/doi/10.1007/s11832-010-0263-9
  7. Lee SJ, Sung IY, Jang DH, Yi JH, Lee JH, Ryu JS. The effect and complication of botulinum toxin type a injection with serial casting for the treatment of spastic equinus foot. Ann Rehabil Med [Internet]. 2011 Jun [cited 2025 Feb 14];35(3):344–53. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309222/

Share

Vasudha Handa

Master's degree, Microbiology, General, Panjab University

arrow-right